Paper Details

  1. Home
  2. Paper Details

Immunomodulatory drugs inhibit TLR4-induced type-1 interferon production independently of Cereblon via suppression of the TRIF/IRF3 pathway.

Author: DubeyPraveen, GemechuYohannes, KishimotoTadamitsu, MillrineDavid, MiyataHaruhiko, NakahamaTaisuke, NyatiKishan, RipleyBarry, TeiMami

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Immunomodulatory drugs (IMiDs) inhibit TLR-induced type-1 interferon production independently of Cereblon, a receptor associated with thalidomide's teratogenic effects. This discovery suggests that the therapeutic properties of IMiDs can be separated from their harmful side effects.
Paper Details　
Original Abstract of the Article :
Thalidomide and its derivatives, collectively referred to as immunomodulatory drugs (IMiDs), are effective inhibitors of inflammation and are known to inhibit TLR-induced TNFα production. The identification of Cereblon as the receptor for these compounds has led to a rapid advancement in our underst...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/intimm/dxw005

データ提供：米国国立医学図書館（NLM）

Immunomodulatory Drugs: A New Pathway for Inhibiting Type-1 Interferon Production

Type-1 interferons, like a desert sandstorm swirling out of control, can contribute to inflammation and autoimmune disorders. This study, like a determined explorer seeking a way to tame the storm, investigates the potential of immunomodulatory drugs (IMiDs) to inhibit the production of these inflammatory mediators.

IMiDs: A Multifaceted Approach to Taming Inflammation

The researchers, like skilled desert navigators, discovered that IMiDs effectively inhibit the production of type-1 interferons by suppressing the TRIF/IRF3 pathway. This finding, like a refreshing oasis in the midst of a sandstorm, suggests a new approach to managing inflammatory disorders.

Health Impact: A Potential New Weapon Against Autoimmune Diseases

This study opens up new avenues for treating disorders characterized by the overproduction of type-1 interferons, such as autoimmune diseases. IMiDs, like a powerful desert shield protecting against the elements, could offer a novel therapeutic approach to managing these conditions.

Dr. Camel's Conclusion

This study sheds light on the multifaceted properties of IMiDs, suggesting their potential to effectively dampen inflammation by inhibiting the production of type-1 interferons. It's like a camel caravan discovering a new route through the desert, offering a promising pathway to managing inflammatory and autoimmune disorders. This research offers a beacon of hope for those battling these debilitating conditions.
Date :
  1. Date Completed 2018-01-30
  2. Date Revised 2021-12-04
Further Info :

Pubmed ID

26865412

DOI: Digital Object Identifier

10.1093/intimm/dxw005

Related Literature

Article Analysis
・Side Effects of pomalidomide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.